Our Technology
Our DAMAST automated system
Our DAMAST automated system has the potential to revolutionize the way antimicrobial susceptibility testing is performed. Thanks to our patented deep-tech technology, we significantly reduce the time required to obtain accurate results. Compact and adaptable, DAMAST is designed to integrate seamlessly into healthcare settings, offering optimal usability with application-specific kits.
Ultra-fast detection
Sensitive and accurate readout
Suitable for direct samples
OUR INNOVATION
DAMOCLES Diagnostics has developed a patented technology for the rapid detection of microorganisms. By analyzing bacterial populations at the subpopulation level using biophysical parameters such as size and density, our technology can observe up to 10 billion bacteria using an integrated spectrophotometer.
This approach enables an ultra-sensitive and precise readout, allowing the rapid detection of antimicrobial effects. As a result, our technology delivers significantly faster results than traditional phenotypic methods.
Traditional phenotypic methods
- ^Extended analysis time (12 to 24 hours)
- ^Global approach without clear differentiation of subpopulations
- ^Results dependent on bacterial growth
- ^General observation of bacterial behavior in the presence of an antibiotic
DAMOCLES DAMAST Technology
- ^Diagnosis within minutes
- ^Subpopulation segmentation (size, density, etc.)
- ^Analysis on direct samples, suitable for complex samples
- ^Precise observation of bacterial behavior in the presence of an antibiotic
Signal analysis
1. Transition from the control population (without antimicrobials):
2. Transition from the treated population and comparison with the control population signal :
